Biosciences

Tesis Biosciences announces project to study veterans and civilians with mild traumatic brain injury

Tesis Biosciences announces project to study veterans and civilians with mild traumatic brain injury

Leave a Comment / Genetics / By

Company in preparation for applying for formal FDA approval PHOENIX, December 9, 2022 /PRNewswire/ — Tesis Biosciences, the leader in targeted genetic sequencing, has announced a study project designed to develop molecular biomarkers to accurately differentiate mild traumatic brain injury (mTBI) from post-traumatic stress disorder (PTSD). ). Enabling accurate diagnosis can improve treatments for people …

Tesis Biosciences announces project to study veterans and civilians with mild traumatic brain injury Read More »

Neurocrine Biosciences presents data on the demographic and clinical characteristics of pediatric patients with SCN8A-related epilepsy at AES 2022

Neurocrine Biosciences presents data on the demographic and clinical characteristics of pediatric patients with SCN8A-related epilepsy at AES 2022

Leave a Comment / Genetics / By

SAN DIEGO, December 2, 2022 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX), a leading neuroscience-focused biopharmaceutical company, today released demographic and clinical data from studies based on genetic screening of children with SCN8A– related epilepsies. Data was collected from over 17,000 patients through Invitee Corporation’s Behind the Seizure® Program, of which Neurocrine Biosciences is a …

Neurocrine Biosciences presents data on the demographic and clinical characteristics of pediatric patients with SCN8A-related epilepsy at AES 2022 Read More »